Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Women's Heart Attack Research Program: Platelet Sub-Study (HARP)

Condition:   Myocardial Infarction
Intervention:  
Sponsor:   New York University School of Medicine
Recruiting - verified January 2017

Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Subjects

Condition:   Non-obstructive Coronary Artery Disease
Interventions:   Drug: Nicorandil;   Drug: Standard treatment
Sponsor:   Merck KGaA
Recruiting - verified January 2017

Mobile Health Strategies for Veterans

Condition:   Coronary Heart Disease
Interventions:   Behavioral: Text Message;   Behavioral: Mobile Application;   Other: Website
Sponsors:   University of California, San Francisco;   San Francisco Veterans Affairs Medical Center
Recruiting - verified January 2017

Brain, Cardiac Hemodynamics and Cognition During Exercise in Subjects With Various Cardiovascular Profiles

Conditions:   Metabolic Syndrome;   Coronary Artery Disease;   Heart Failure
Intervention:   Other: Exercise and Cognitive testing
Sponsor:   Montreal Heart Institute
Active, not recruiting - verified January 2017

Influence of Age, Weight and Ethnic Background on Blood Pressure

Conditions:   Cardiovascular Diseases;   Vascular Diseases;   Hypertension
Interventions:   Other: Brief lifestyle/medical history questionnaire;   Other: Anthropometric measures;   Other: Blood pressure and arterial stiffness;   Other: Cardiac output and lung function;   Other: Heart rate variability;   Other: Blood sample & spot urine sample;   Other: 24 hour ambulatory blood pressure monitor;   Other: 24 hour urine collection;   Other: Echocardiograph: Left ventricular mass;   Other: Large artery structure: Carotid intima-media thickness;   Other: Small artery structure: Minimum forearm vascular resistance;   Other: Large artery endothelial function;   Other: Small artery endothelial function: Forearm blood flow;   Other: Dundee step test;   Other: Detailed haemodynamic response to submaximal exercise;   Other: Cardiopulmonary fitness: Maximum oxygen consumption;   Other: Haemodynamic response to mental stress
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   University of Cambridge
Not yet recruiting - verified January 2017

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Conditions:   Estrogen Deficiency;   Cardiovascular Disease (CVD);   Hypothalamic Amenorrhea
Interventions:   Drug: 17beta Estradiol;   Drug: Transdermal placebo patch;   Drug: Progesterone;   Drug: Placebo Pill
Sponsor:   Cedars-Sinai Medical Center
Not yet recruiting - verified January 2017

Pulmonary Vascular Disease Phenomics Program PVDOMICS

Condition:   Pulmonary Arterial Hypertension
Intervention:   Other: No Intervention
Sponsors:   The Cleveland Clinic;   Brigham and Women's Hospital;   Columbia University;   Weill Medical College of Cornell University;   Johns Hopkins University;   Mayo Clinic;   University of Arizona;   Vanderbilt University
Recruiting - verified December 2016

Women's Heart Attack Research Program: Stress Ancillary Study

Condition:   Myocardial Infarction
Interventions:   Behavioral: Enhanced Usual Care;   Behavioral: Stress Management;   Device: Actigraph
Sponsor:   New York University School of Medicine
Recruiting - verified January 2017

Women's Heart Attack Research Program- Imaging Study

Condition:   Myocardial Infarction
Interventions:   Device: OCT;   Other: CMR
Sponsor:   New York University School of Medicine
Recruiting - verified January 2017

CT COMPARE: CT COronary Angiography to Measure PlAque REduction

Condition:   Cardiovascular Disease
Interventions:   Drug: Rosuvastatin;   Drug: Atorvastatin
Sponsor:   National Institutes of Health Clinical Center (CC)
Recruiting - verified November 2016

Evaluation to Assess Cognitive Training for the Prevention of Post-operative Cognitive Decline

Condition:   Cognitive Dysfunction
Intervention:   Behavioral: Cognitive training program RehaCom®
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified January 2017

Prebiotic in Preventing Low Birth Weight

Conditions:   Birth Weight <2500gm;   Genitourinary Tract Infection
Interventions:   Dietary Supplement: Fructooligosaccharide;   Dietary Supplement: Pocari-Sweat
Sponsors:   International Centre for Diarrhoeal Disease Research, Bangladesh;   Karolinska Institutet;   Swedish International Development Cooperation Agency (SIDA)
Recruiting - verified December 2016

Peer Mentored Approaches for Women With Coronary Artery Disease ("4-Steps")

Condition:   Coronary Artery Disease
Interventions:   Behavioral: Peer Mentor;   Behavioral: Transcendental Meditation
Sponsor:   Weill Medical College of Cornell University
Recruiting - verified January 2017

Frailty in Elderly Patients Receiving Cardiac Interventional Procedures

Condition:   Aged
Intervention:   Other: frailty evaluation
Sponsor:   University Hospital of Ferrara
Active, not recruiting - verified January 2017

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

Condition:   Atherosclerosis
Intervention:  
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2017

Effects of Exercise Training on Cardiovascular Health in Middle-aged Women

Conditions:   Menopause;   Cardiac Function Impaired;   Cardiovascular Diseases;   Blood Platelet Disorders;   Metabolic Diseases
Intervention:   Behavioral: Spinning
Sponsors:   University of Copenhagen;   Glostrup University Hospital, Copenhagen;   Rigshospitalet, Denmark
Active, not recruiting - verified January 2017

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified December 2016

Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)

Condition:   Chronic Obstructive Airway Disease
Interventions:   Device: Bi-level positive airway pressure (BPAP);   Drug: Oxygen;   Device: CPAP
Sponsors:   Brigham and Women's Hospital;   Massachusetts General Hospital
Withdrawn - verified January 2017

PRE-DETERMINE Cohort Study

Conditions:   Coronary Artery Disease;   Left Ventricular Dysfunction;   Sudden Cardiac Death
Intervention:  
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   St. Jude Medical;   Northwestern University;   Roche Diagnostics Corporation;   Quintiles, Inc.
Active, not recruiting - verified January 2017

Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

Condition:   Coronary Artery Disease
Interventions:   Drug: Exercise plus Regadenoson (Lexercise);   Drug: Regadenoson (Lexiscan)
Sponsor:   Brigham and Women's Hospital
Recruiting - verified January 2017

IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)

Conditions:   Heart Failure;   Coronary Artery Disease;   Ischemic Cardiomyopathy;   Non-ischemic Cardiomyopathy
Interventions:   Other: Advanced cardiac imaging;   Other: Standard Cardiac Imaging
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR);   The Finnish Funding Agency for Technology and Innovation (TEKES)
Recruiting - verified January 2017

Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial

Conditions:   Preeclampsia;   Pregnancy Induced Hypertension;   Gestational Hypertension;   Chronic Hypertension;   Superimposed Preeclampsia
Interventions:   Drug: labetalol (seizure prevention);   Drug: MgSO4 (seizure prevention)
Sponsor:   Baylor College of Medicine
Withdrawn - verified January 2017